IL116586A0 - A composition for modulating apoptosis - Google Patents

A composition for modulating apoptosis

Info

Publication number
IL116586A0
IL116586A0 IL11658695A IL11658695A IL116586A0 IL 116586 A0 IL116586 A0 IL 116586A0 IL 11658695 A IL11658695 A IL 11658695A IL 11658695 A IL11658695 A IL 11658695A IL 116586 A0 IL116586 A0 IL 116586A0
Authority
IL
Israel
Prior art keywords
composition
modulating apoptosis
apoptosis
modulating
Prior art date
Application number
IL11658695A
Other languages
English (en)
Original Assignee
Cird Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird Galderma filed Critical Cird Galderma
Publication of IL116586A0 publication Critical patent/IL116586A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11658695A 1994-12-29 1995-12-27 A composition for modulating apoptosis IL116586A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415884A FR2728790B1 (fr) 1994-12-29 1994-12-29 Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial

Publications (1)

Publication Number Publication Date
IL116586A0 true IL116586A0 (en) 1996-03-31

Family

ID=9470424

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11658695A IL116586A0 (en) 1994-12-29 1995-12-27 A composition for modulating apoptosis

Country Status (24)

Country Link
US (1) US5744499A (xx)
EP (1) EP0723778B1 (xx)
JP (1) JP2000515845A (xx)
KR (1) KR100310499B1 (xx)
AR (1) AR001783A1 (xx)
AT (1) ATE191339T1 (xx)
AU (1) AU704064B2 (xx)
BR (1) BR9510509A (xx)
CA (1) CA2166243C (xx)
DE (1) DE69516107T2 (xx)
DK (1) DK0723778T3 (xx)
ES (1) ES2147272T3 (xx)
FI (1) FI972780A (xx)
FR (1) FR2728790B1 (xx)
GR (1) GR3033732T3 (xx)
HU (1) HUT77490A (xx)
IL (1) IL116586A0 (xx)
NO (1) NO973034L (xx)
NZ (1) NZ298831A (xx)
PL (1) PL182597B1 (xx)
PT (1) PT723778E (xx)
RU (1) RU2160103C2 (xx)
WO (1) WO1996020701A1 (xx)
ZA (1) ZA9511015B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9517622D0 (en) * 1995-08-29 1995-11-01 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
FR2761606B1 (fr) * 1997-04-08 1999-05-14 Cird Galderma Utilisation de derives aminothiolesters dans le domaine pharmaceutique
EP0908179A1 (en) * 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
ATE512233T1 (de) * 1998-02-23 2011-06-15 Phylonix Pharmaceuticals Inc Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten
US6656449B1 (en) 1998-02-23 2003-12-02 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
US6761876B2 (en) 1998-12-01 2004-07-13 Phylonix Pharmaceuticals, Inc. Methods for introducing helterologous cells into fish
US7951989B2 (en) * 1998-02-23 2011-05-31 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
CA2322878C (en) * 1998-03-16 2008-05-06 Somerset Pharmaceuticals, Inc. Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
FR2777001B1 (fr) * 1998-04-01 2000-06-09 Cird Galderma Derives de l'acide 6,8-dimercaptooctanoique substitues en 6-s et/ou en 8-s par le radical (3-methylthiopropanoyl) et compositions pharmaceutiques destinees au traitement des tumeurs cancereuses
TW544310B (en) * 1998-04-02 2003-08-01 Ajinomoto Kk Amino acid derivatives and anti-inflammatory agents
EP1231886A4 (en) * 1999-11-24 2005-10-12 Access Business Group Int Llc COMPOSITION FOR THE SKIN SURFACE
AU784538B2 (en) * 1999-12-06 2006-04-27 Geistlich Pharma Ag Use of methylol-containing compounds to treat tumors
US20080124409A1 (en) * 2000-11-21 2008-05-29 Access Business Group International Llc Topical Skin Compositions, Their Preparation, and Their Use
US20070003536A1 (en) * 2000-11-21 2007-01-04 Zimmerman Amy C Topical skin compositions, their preparation, and their use
WO2002094271A1 (en) * 2001-05-15 2002-11-28 Faulk Pharmaceuticals, Inc. Targeted delivery of bioaffecting compounds for the treatment of cancer
US20030129262A1 (en) * 2001-08-30 2003-07-10 Epner Daniel E. Methionine restriction for cancer therapy
US20030143645A1 (en) * 2001-09-14 2003-07-31 Haystead Timothy A. Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets
JP2004020220A (ja) * 2002-06-12 2004-01-22 Pioneer Electronic Corp 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム
US20050152995A1 (en) * 2003-06-27 2005-07-14 Chen Dong F. Methods and compositions for promoting axon regeneration and cell replacement therapy
WO2009144253A1 (en) * 2008-05-29 2009-12-03 Karolinska Institutet Innovations Ab Compounds comprising a 3-pyridinol or 5-pyrimidinol ring having an organoseleno or organotelluro substituent for use as antioxidants
SE537517C2 (sv) 2012-12-14 2015-05-26 Stora Enso Oyj Våtlagt arkmaterial innefattande mikrofibrillerad cellulosasamt förfarande för tillverkning därav
WO2017005910A1 (en) * 2015-07-09 2017-01-12 Metabolic Explorer Methionine hydroxy analog (mha) pathways for production by fermentation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5716898A (en) * 1980-07-03 1982-01-28 Kureha Chem Ind Co Ltd Prostaglandin controller containing aminobenzoic derivative
HU201240B (en) * 1987-03-18 1990-10-28 Caola Kozmetikai Cosmetical composition for regeneration of skin
FR2673530B1 (fr) * 1991-03-06 1995-05-19 Monique Moreau Extraits de feuilles de murier, antiradicalaires et antimalondialdehyde.

Also Published As

Publication number Publication date
FI972780A0 (fi) 1997-06-27
MX9704491A (es) 1997-10-31
PT723778E (pt) 2000-09-29
BR9510509A (pt) 1998-07-07
NO973034D0 (no) 1997-06-27
DE69516107T2 (de) 2000-11-16
EP0723778B1 (fr) 2000-04-05
ES2147272T3 (es) 2000-09-01
US5744499A (en) 1998-04-28
CA2166243A1 (fr) 1996-06-30
ZA9511015B (en) 1996-08-12
FR2728790A1 (fr) 1996-07-05
AU4451296A (en) 1996-07-24
PL182597B1 (pl) 2002-02-28
NO973034L (no) 1997-08-29
DK0723778T3 (da) 2000-07-10
AU704064B2 (en) 1999-04-15
HUT77490A (hu) 1998-05-28
FI972780A (fi) 1997-06-27
WO1996020701A1 (fr) 1996-07-11
RU2160103C2 (ru) 2000-12-10
KR100310499B1 (ko) 2001-12-12
NZ298831A (en) 2001-04-27
DE69516107D1 (de) 2000-05-11
EP0723778A1 (fr) 1996-07-31
GR3033732T3 (en) 2000-10-31
AR001783A1 (es) 1997-12-10
JP2000515845A (ja) 2000-11-28
ATE191339T1 (de) 2000-04-15
PL320963A1 (en) 1997-11-24
CA2166243C (fr) 2003-07-01
KR970706807A (ko) 1997-12-01
FR2728790B1 (fr) 1997-01-24

Similar Documents

Publication Publication Date Title
IL116586A0 (en) A composition for modulating apoptosis
GB2286835B (en) A paver
EP0693844A3 (en) Digital modulator for quadrature modulation
GB9404706D0 (en) Compounds
IL117886A0 (en) Switched-inverter modulator
GB9406043D0 (en) Compounds
ZA953954B (en) A mineral-fiber composition
DE69601083D1 (en) Passiver akusto-optischer modulator
GB2317934B (en) A seal
HU9600085D0 (en) A mineral-fiber composition
KR940020549U (ko) 잠금방지 조절기(Antilook Modulator)
SG54285A1 (en) Self-adjusting modulator
GB9400413D0 (en) Compounds
GB9403199D0 (en) Compounds
GB9402197D0 (en) Compounds
GB2295534B (en) Scraper
GB9402041D0 (en) Compounds
ZA954853B (en) A mineral-fibre composition
GB9416459D0 (en) New compounds
GB2320149B (en) Modulators
GB2339983B (en) A modulator
GB9404354D0 (en) Seals
GB2290528B (en) Dispenser seal
HK1010809A1 (en) Self-adjusting modulator
GB9402603D0 (en) Compounds

Legal Events

Date Code Title Description
FF Patent granted